Cargando…
PD-L1 protein expression and copy number gains in HIV-positive locally advanced cervical cancer
BACKGROUND: The programmed death-1/programmed death-ligand-1 (PD-1/PD-L1) axis may represent a target for cervical cancer; however, it is poorly understood in human immunodeficiency virus (HIV)-infected patients. METHODS: We evaluated HIV-positive (n = 42) and HIV-negative (n = 110) women with locall...
Autores principales: | Loharamtaweethong, Kongsak, Puripat, Napaporn, Praditphol, Niphon, Thammasiri, Jidapa, Tangitgamol, Siriwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580136/ https://www.ncbi.nlm.nih.gov/pubmed/33149767 http://dx.doi.org/10.1177/1758835920963001 |
Ejemplares similares
-
Impact of antiretroviral drugs on PD-L1 expression and copy number gains with clinical outcomes in HIV-positive and -negative locally advanced cervical cancers
por: Loharamtaweethong, Kongsak, et al.
Publicado: (2019) -
Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer
por: Inoue, Yusuke, et al.
Publicado: (2016) -
c-myc copy number gain is a powerful prognosticator of disease outcome in cervical dysplasia
por: Kübler, Kirsten, et al.
Publicado: (2014) -
Clinical impacts of genomic copy number gains at Xq28
por: Yamamoto, Toshiyuki, et al.
Publicado: (2014) -
Fabrication and characterization of polycaprolactone/cellulose acetate blended nanofiber mats containing sericin and fibroin for biomedical application
por: Barnthip, Naris, et al.
Publicado: (2022)